QUILYPSO
DEAD

Serial Number

87027255

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 6, 2016

Add to watchlist:

No watchlists yet
View on USPTO

QUILYPSO Trademark

Serial Number: 87027255

QUILYPSO is a trademark filed by NOVARTIS AG on May 6, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 6, 2016

Registration Date

Not Registered

Published for Opposition

September 6, 2016

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 2, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 2, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2019 EXRA
SOU EXTENSION 5 GRANTED
May 2, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 2, 2019 AITU
SOU EXTENSION 5 FILED
Apr 29, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 29, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2018 EXRA
SOU EXTENSION 4 GRANTED
Oct 31, 2018 EX4G
SOU EXTENSION 4 FILED
Oct 31, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 31, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2018 EXRA
SOU EXTENSION 3 GRANTED
Apr 25, 2018 EX3G
SOU EXTENSION 3 FILED
Apr 25, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 25, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2017 EXRA
SOU EXTENSION 2 GRANTED
Oct 31, 2017 EX2G
SOU EXTENSION 2 FILED
Oct 31, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 31, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2017 EXRA
SOU EXTENSION 1 GRANTED
Apr 25, 2017 EX1G
SOU EXTENSION 1 FILED
Apr 25, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 25, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 1, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2016 CNSA
ASSIGNED TO EXAMINER
Jul 22, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2016 NWOS
NEW APPLICATION ENTERED
May 10, 2016 NWAP